AstraZeneca (Brazil)
In research, AstraZeneca (Brazil) stands highest in Medicine (#5,896 of 10,443 worldwide) and Health Sciences (#7,495 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #9,654 of 28,054 · #8,904 all time
- Rank in Brazil
- #136 of 714
- Research works
- 694 ▼ 4% vs 2013–17
- Citations
- 20k 29.0 per fractional work
- Top-10% rate
- 15.3% record average 16.5%
- Open access
- 51% world 28%
What is AstraZeneca (Brazil) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,896 of 10,443 | 14.9% | 84 | #5310 | |
| Health SciencesDomain | #7,495 of 11,982 | 14.5% | 88 | #6099 |
Each strip is that field’s whole ranked pool, with the notch where AstraZeneca (Brazil) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.9×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 6.9×
- Immunology and Microbiology 5.8×
- Biochemistry, Genetics and Molecular Biology 3.5×
- Medicine 2.5×
- Chemistry 2.4×
- Economics, Econometrics and Finance 1.9×
- Veterinary 1.2×
- Dentistry 1.2×
- Mathematics 1.1×
- Chemical Engineering 1.1×
- Health Professions 0.6×
- Computer Science 0.4×
- Neuroscience 0.4×
- Materials Science 0.3×
- Nursing 0.3×
- Decision Sciences 0.3×
- Environmental Science 0.3×
- Engineering 0.2×
- Agricultural and Biological Sciences 0.2×
- Psychology 0.2×
- Social Sciences 0.2×
- Business, Management and Accounting 0.1×
- Physics and Astronomy 0.0×
Which keywords describe research at AstraZeneca (Brazil)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Treatment, Epidemiology, Genetics, Immunology, Clinical Trials, Monoclonal Antibodies and Asthma.
- Rituximab
- Cell Death
- Genetic Variants
- Health Utility Measures
- Prognostic Factors
- Metabolism
- Targeted Therapy
- Immunity
- Glycosylation
- Prognosis
- Autoantibodies
- Chemotherapy
- Eosinophils
- Monoclonal Antibodies
- Cancer Therapy
- Cardiovascular Disease
- Clinical Trials
- Diagnosis
- Cancer
- Inflammation
- Epidemiology
- Treatment
- Quality of Life
- Genetics
- Immunotherapy
- Asthma
- Immunology
- Allergic Diseases
- Transcriptional Regulation
- Heart Failure
- Medicinal Chemistry
- Therapeutic Antibodies
- Tumor Microenvironment
- Pharmacokinetics
- Guidelines
- Breast Cancer
- Cost-effectiveness Analysis
- Chronic Kidney Disease
- Biopharmaceuticals
- Immunogenicity
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology15▲ 2.2×43 topics
- Inflammation14▲ 3.9×44 topics
- Treatment12▲ 5.6×18 topics
- Cancer8▲ 3.4×32 topics
- Quality of Life7▲ 2.8×14 topics
- Diagnosis7▲ 4.2×19 topics
- Genetics7▲ 5.6×7 topics
- Clinical Trials6▲ 5.5×13 topics
- Immunotherapy6▲ 4.9×14 topics
- Cardiovascular Disease6▲ 2.9×21 topics
- Asthma6▲ 32×2 topics
- Cancer Therapy6▲ 5.5×12 topics
- Immunology6▲ 30×2 topics
- Monoclonal Antibodies6▲ 35×3 topics
- Allergic Diseases5▲ 51×1 topic
- Eosinophils5▲ 51×1 topic
- Transcriptional Regulation5▲ 18×8 topics
- Chemotherapy5▲ 4.0×13 topics
- Heart Failure5▲ 6.1×9 topics
- Autoantibodies5▲ 11×7 topics
- Medicinal Chemistry5▲ 9.4×8 topics
- Prognosis5▲ 7.9×7 topics
- Therapeutic Antibodies4▲ 37×2 topics
- Glycosylation4▲ 22×3 topics
- Tumor Microenvironment4▲ 5.7×7 topics
- Immunity4▲ 5.7×7 topics
- Pharmacokinetics4▲ 8.8×4 topics
- Targeted Therapy4▲ 10×4 topics
- Guidelines4▲ 4.8×8 topics
- Metabolism4▲ 4.2×12 topics
- Breast Cancer4▲ 8.3×8 topics
- Prognostic Factors4▲ 4.6×9 topics
- Cost-effectiveness Analysis3▲ 22×1 topic
- Health Utility Measures3▲ 22×1 topic
- Chronic Kidney Disease3▲ 7.6×6 topics
- Genetic Variants3▲ 10×5 topics
- Biopharmaceuticals3▲ 33×3 topics
- Cell Death3▲ 7.3×6 topics
- Immunogenicity3▲ 39×2 topics
- Rituximab3▲ 11×4 topics
Which research topics does AstraZeneca (Brazil) publish most on?
By volume in 2022–2025: Asthma and respiratory diseases, Health Systems, Economic Evaluations, Quality of Life, Genomics and Rare Diseases and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Asthma and respiratory diseases Physiology 5 works
- 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 3 works
- 3 Genomics and Rare Diseases Genetics 3 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 5 Economic and Financial Impacts of Cancer Economics and Econometrics 3 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 7 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 8 Myasthenia Gravis and Thymoma Neurology 2 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 10 Protein purification and stability Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AstraZeneca (Brazil)'s research output changed?
Output in 2018–2022 was 4% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in São Paulo
- Universidade de São Paulo
- Universidade Estadual Paulista (Unesp)
- Universidade Federal de São Paulo
- Pontifícia Universidade Católica de São Paulo
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Hospital Universitário da Universidade de São Paulo
- Universidade Brasil
- Universidade Presbiteriana Mackenzie
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.